CytoSorbents Says Real-World Matched Analysis Of 587 Urgent CABG Patients On Ticagrelor Showed 37% Relative Reduction In Severe Bleeding With CytoSorb; Plans New DrugSorb-ATR De Novo Submission In Early 2027